Korro to Present at the 2026 Jefferies Global Healthcare Conference in London
Key Highlights
- ➤Korro CEO Ram Aiyar will present at the 2026 Jefferies Global Healthcare Conference
- ➤Presentation scheduled for November 19 at 8:00 AM GMT
- ➤Live webcast and 90-day replay will be available through Korro’s investor website
Expert Statements
Ram Aiyar, Chief Executive Officer and President of Korro Bio
“OPERA provides precise, tissue-directed delivery of RNA-editing oligonucleotides (REOs) that modify the targeted native mRNA transcript to repair or form a de-novo protein with enhanced functionality.”
CAMBRIDGE, Mass., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company leveraging a novel Oligonucleotide Promoted Editing of RNA (OPERA(®)) platform to develop a new class of genetic medicines for rare and highly prevalent diseases, today announced that Ram Aiyar, Ph.D., Chief Executive Officer and President, will present at the 2026 Jefferies Global Healthcare Conference in London being held on November 16-19, 2026. Dr. Aiyar’s presentation will take place on Thursday, November 19(th) at 8:00 AM GMT (3:00 AM ET).
A live webcast of the presentation can be accessed on the “Events & Presentations” page in the investor section of Korro’s website at www.korrobio.com. Following the presentation a replay of the event will be available for 90 days.
Get started
Create a free account to read the full story.